Lv2
180 积分 2024-08-12 加入
Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group
1天前
待确认
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2个月前
已完结
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations
4个月前
已完结
Synthetic Routes and Clinical Application of New Drugs Approved by EMA During 2023
4个月前
已完结
Using real-world evidence to evaluate broad panel vs. sequential single and narrow panel sequencing in members with non-small cell lung cancer (NSCLC)
5个月前
已关闭
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in China
5个月前
已完结
[Consensus on the molecular residual disease testing in solid tumor]
5个月前
已完结
Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer A Phase 2 Clinical Trial
5个月前
已完结
Real-World Safety and Efficacy of Consolidation Durvalumab After Chemoradiation Therapy for Stage III Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis
6个月前
已完结
111P Real-world treatment patterns and clinical outcomes in Chinese stage III non-small cell lung cancer (NSCLC) patients: Results of MOOREA study
6个月前
已完结
皖公网安备34019202002308
